- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05399901
M-mode Ultrasonography in the Assessment and Treatment of Pelviperineal Dysfunctions (PerineUM) (PerineUM)
Use of Transabdominal M-mode Ultrasonography in the Assessment and Treatment of Pelviperineal Dysfunctions
Objectives: To analyze the Mode M ultrasound use in the assessment of pelvic floor musculature (PFM) and in the rehabilitation of motor control in pelviperineal dysfunctions that affect the support of pelvic organs, urinary and fecal continence and reproductive and sexual functions.
Methodology: A cross-sectional descriptive study will be followed by a randomized clinical trial. There will be two samples: a sample of volunteers without PFM dysfunction; and a sample of patients with pelviperineal dysfunction derived from health centers in the Region of Murcia. An intra- and interobserver reliability study of transabdominal M-mode ultrasound of PFM will be performed. Then, a cross-sectional descriptive study of the functional behavior of PFM will be used in different functional situations such as: voluntary contraction at maximum force, fast contraction, Valsalva maneuver and forced cough. The following ultrasound variables will be measured: direction and amount of displacement, speed of displacement and time of contraction. Correlations between ultrasound variables and sociodemographic and clinical variables will be analyzed. The randomized clinical trial will compare a PFM contraction awareness treatment based on endocavitary digital contact with a motor learning program based on transabdominal mode M ultrasound biofeedback.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: MARIA ELENA DEL BAÑO ALEDO, PhD
- Phone Number: 647193115
- Email: mbano@um.es
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with pelvic floor dysfunction derived from the pelvic floor unit of HLA La Vega in the city of Murcia diagnosed by the doctor and without previous training in pelvic floor muscles contraction.
Exclusion Criteria:
- Pregnancy, a history of pelvic floor surgery in the previous year, neurological injury with affectation of the sacral reflex from S2 to S4, previous delivery in a period of less than 6 weeks or known or suspected urinary tract infection.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EMG BFB
An educational program will be implemented, and active exercises of the PFM will be performed using verbal instructions together with electromyographic biofeedback (BFB).
|
Active exercises of the pelvic floor muscles and verbal instructions and EMG Biofeedback
|
|
Experimental: M-mode US
An educational program will be implemented, and active exercises of the PFM will be performed using verbal instructions together with transabdominal M-mode ultrasound biofeedback (US).
|
Active exercises of the pelvic floor muscles and verbal instructions and M-mode Ultrasound Biofeedback
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the self efficacy expectations in performing pelvic floor exercises.
Time Frame: At baseline and after the intervention (1 week from baseline)
|
It will be assessed by the Broome Pelvic Muscle Self-Efficacy Scale (PMSES) Spanish version.
Self-efficacy expectations, specifically for performing pelvic floor exercises, are measured with 14 items with responses between 0 and 100.
One hundred represents high level of confidence.
|
At baseline and after the intervention (1 week from baseline)
|
|
Changes in the outcome expectations for pelvic-floor exercise treatment.
Time Frame: At baseline and after the intervention (1 week from baseline)
|
It will be assessed by the Broome Pelvic Muscle Self-Efficacy Scale (PMSES) Spanish version.
Outcome expectations are measured with 9 items with responses between 0 and 100.
One hundred represents high level of confidence.
|
At baseline and after the intervention (1 week from baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the displacement of the base of the bladder during voluntary contraction of the pelvic floor.
Time Frame: At baseline and after the intervention (1 hour from baseline)
|
It will be measured by Ultrasonography.
|
At baseline and after the intervention (1 hour from baseline)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: MARIA ELENA DEL BAÑO ALEDO, PhD, Murcia University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PerineUM2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.